340B Transparency Act

Hozzl · 2024-12-18T21:20:15Z

Explore the details of House Bill 3290 340B Transparency Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/18/2024, 9:20 PM

Summary of Bill HR 3290

The Bill 118 hr 3290, also known as the 340B Transparency Act, aims to increase transparency and accountability in the 340B Drug Pricing Program. This program requires drug manufacturers to provide discounts on outpatient drugs to certain healthcare facilities that serve low-income and vulnerable populations.

The bill requires the Department of Health and Human Services (HHS) to establish a publicly accessible website that provides information on the 340B program, including the prices paid by covered entities for drugs purchased through the program. This information will help ensure that the program is being used as intended and that the discounts provided by drug manufacturers are being passed on to patients in need.

Additionally, the bill requires covered entities to report certain information to HHS, including the total amount of discounts received through the program and how those discounts are being used. This reporting requirement will help HHS monitor the program and ensure that it is effectively serving its intended purpose. Overall, the 340B Transparency Act aims to increase transparency and accountability in the 340B Drug Pricing Program, ultimately ensuring that low-income and vulnerable populations have access to affordable medications.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 3290

Bill HR 3290 is currently in the status of Bill Introduced since May 15, 2023. Bill HR 3290 was introduced during Congress 118 and was introduced to the House on May 15, 2023. Bill HR 3290's most recent activity was Placed on the Union Calendar, Calendar No. 628. as of November 20, 2024

Bipartisan Support of Bill HR 3290

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 3290

Primary Policy Focus

Health

Potential Impact Areas

Accounting and auditingGovernment information and archivesHealth care costs and insurancePrescription drugs

Alternate Title(s) of Bill HR 3290

To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program.To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program.

Start holding our government accountable!

Comments

Sponsors and Cosponsors of HR 3290

Larry Bucshon

Indiana(Republican)

Latest Bills

International Nuclear Energy Financing Act of 2025

Bill HR 1474April 5, 2025

Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.

Bill HCONRES 14April 5, 2025

Leveraging Artificial Intelligence to Streamline the Code of Federal Regulations Act of 2025

Bill S 1110April 5, 2025

A bill to establish clear and consistent biological definitions of male and female.

Bill S 1147April 5, 2025

A bill to amend title 28, United States Code, to prohibit the issuance of national injunctions, and for other purposes.

Bill S 1206April 5, 2025

340B Accountability Act of 2023

Bill S 1133December 15, 2023